Nu-Med Plus (NUMD) Capital Expenditures Growth (1y) (2013 - 2014)
Nu-Med Plus (NUMD) Capital Expenditures Growth (1y) (2013 - 2014) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.26 Bn | 175.96 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.79 Bn | 125.92 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 108.56 Bn | 99.34 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 68.31 Bn | 66.86 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 47.27 Bn | 43.60 Bn | 1.29 Bn | 15.89% |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn | -11.95% |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.12 Bn | 1.98 Bn | 106.98% |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.40 Bn | 2.07 Bn | -47.73% |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | -104.04% |
| Dec 31, 2013 | 75,766.67% |
| Sep 30, 2013 | 167,800.00% |